Navigating the transition from research to clinical-scale cell therapy manufacture
Steven Feldman, Johannes Fruehauf, Mary Ann Santos
Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics
Jens Björkman, Andreas Hecker
Manufacturing Quality Control for Plasmid DNA Critical Starting Materials
A Frazer, L R. Salvitti, S Lovatt et al
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing
K Bruce, K Bharti, I Barbaric et al
Strategies for streamlined manufacturing and analytics in CGT development
Laura Mueller, Silvio Weber, Dirk Windgassen
Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells
Mindy Miller, Nathan Frank
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success
Peter Szaraz, Tessel Hammink
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel
